Últimos Artículos de Cardiovascular Diabetology
- Evaluating the impact of glucokinase activation on risk of cardiovascular disease: a Mendelian randomisation analysis
- Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure
- Incremental prognostic value of triglyceride glucose index additional to coronary artery calcium score in asymptomatic low-risk population
- Plasma mannose as a novel marker of myocardial infarction across different glycaemic states: a case control study
- Eliminating exogenous insulin therapy in patients with type 2 diabetes by duodenal ablation and GLP-1RA decreases risk scores for cardiovascular events
- Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system
- Nut consumption is associated with a shift of the NMR lipoprotein subfraction profile to a less atherogenic pattern among older individuals at high CVD risk
- Immune-inflammatory biomarkers and the risk of cardiac injury in COVID-19 patients with diabetes: a retrospective cohort study
- Effect of dapagliflozin on the prognosis of patients with acute myocardial infarction undergoing percutaneous coronary intervention
- Association between triglyceride glucose index, coronary artery calcification and multivessel coronary disease in Chinese patients with acute coronary syndrome
- CCL7 as a novel inflammatory mediator in cardiovascular disease, diabetes mellitus, and kidney disease
- Professor Alexander Tenenbaum: obituary
- Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study
- Time course of the triglyceride glucose index accumulation with the risk of cardiovascular disease and all-cause mortality
- Effect of empagliflozin on left ventricular contractility and peak oxygen uptake in subjects with type 2 diabetes without heart disease: results of the EMPA-HEART trial
- Prognostic value of soluble ST2, high-sensitivity cardiac troponin, and NT-proBNP in type 2 diabetes: a 15-year retrospective study
- Cardiovascular and metabolic morbidity in women with previous gestational diabetes mellitus: a nationwide register-based cohort study
- Long-term cardiovascular prognosis of patients with type 1 diabetes after myocardial infarction
- Anti-obesity therapy for cardiovascular disease prevention: potential expected roles of glucagon-like peptide-1 receptor agonists
- Higher pulse wave velocity in young adult offspring of mothers with type 1 diabetes: a case–control study